Udo Buchholz

Udo Buchholz

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2011 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
UBUdo Buchholz
Udo Buchholz
HBHelen Bernard
Helen Bernard
DWDirk Werber
Dirk Werber
MBMerle M. Böhmer
Merle M. Böhmer
CRCornelius Remschmidt
Cornelius Remschmidt
MKMichael Kühne
Michael Kühne
A large outbreak of the hemolytic–uremic syndrome caused by Shiga-toxin–producing Escherichia coli O104:H4 occurred in Germany in May 2011. The source of infection was undetermined.

26 January 2012 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
TSThorsten Suess
Thorsten Suess
CRCornelius Remschmidt
Cornelius Remschmidt
SSSusanne Schink
Susanne Schink
BSBrunhilde Schweiger
Brunhilde Schweiger
ANAndreas Nitsche
Andreas Nitsche
UBUdo Buchholz
Udo Buchholz
Previous controlled studies on the effect of non-pharmaceutical interventions (NPI) - namely the use of facemasks and intensified hand hygiene - in preventing household transmission of influenza have not produced definitive results. We aimed to investigate efficacy, acceptability, and tolerability of NPI in households with influenza index patients.

6 October 2006 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
KPKlaudia Porten
Klaudia Porten
JRJürgen Rissland
Jürgen Rissland
ATAlmira Tigges
Almira Tigges
SBSusanne Broll
Susanne Broll
WHWilfried Hopp
Wilfried Hopp
UBUdo Buchholz
Udo Buchholz
Background: In May 2003 the Soest County Health Department was informed of an unusually large number of patients hospitalized with atypical pneumonia. Methods: In exploratory interviews patients mentioned having visited a farmers' market where a sheep had lambed. Serologic testing confirmed the diagnosis of Q fever. We asked local health departments in Germany to identiy notified Q fever patients who had visited the farmers market. To investigate risk factors for infection we conducted a case control study (cases were Q fever patients, controls were randomly selected Soest citizens) and a cohort study among vendors at the market. The sheep exhibited at the market, the herd from which it originated as well as sheep from herds held in the vicinity of Soest were tested for Coxiella burnetii (C. burnetii). Results: A total of 299 reported Q fever cases was linked to this outbreak. The mean incubation period was 21 days, with an interquartile range of 16–24 days. The case control study identified close proximity to and stopping for at least a few seconds at the sheep's pen as significant risk factors. Vendors within approximately 6 meters of the sheep's pen were at increased risk for disease compared to those located farther away. Wind played no significant role. The clinical attack rate of adults and children was estimated as 20% and 3%, respectively, 25% of cases were hospitalized. The ewe that had lambed as well as 25% of its herd tested positive for C. burnetii antibodies. Conclusion: Due to its size and point source nature this outbreak permitted assessment of fundamental, but seldom studied epidemiological parameters. As a consequence of this outbreak, it was recommended that pregnant sheep not be displayed in public during the 3rd trimester and to test animals in petting zoos regularly for C. burnetii.

11 December 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TSThorsten Suess
Thorsten Suess
CRCornelius Remschmidt
Cornelius Remschmidt
SSSusanne Schink
Susanne Schink
BSBrunhilde Schweiger
Brunhilde Schweiger
AHAlla Heider
Alla Heider
UBUdo Buchholz
Udo Buchholz
Influenza viral shedding studies provide fundamental information for preventive strategies and modelling exercises. We conducted a prospective household study to investigate viral shedding in seasonal and pandemic influenza between 2007 and 2011 in Berlin and Munich, Germany. Study physicians recruited index patients and their household members. Serial nasal specimens were obtained from all household members over at least eight days and tested quantitatively by qRT-PCR for the influenza virus (sub)type of the index patient. A subset of samples was also tested by viral culture. Symptoms were recorded daily. We recruited 122 index patients and 320 household contacts, of which 67 became secondary household cases. Among all 189 influenza cases, 12 were infected with seasonal/prepandemic influenza A(H1N1), 19 with A(H3N2), 60 with influenza B, and 98 with A(H1N1)pdm09. Nine (14%) of 65 non-vaccinated secondary cases were asymptomatic/subclinical (0 (0%) of 21 children, 9 (21%) of 44 adults; p = 0.03). Viral load among patients with influenza-like illness (ILI) peaked on illness days 1, 2 or 3 for all (sub)types and declined steadily until days 7–9. Clinical symptom scores roughly paralleled viral shedding dynamics. On the first day prior to symptom onset 30% (12/40) of specimens were positive. Viral load in 6 asymptomatic/subclinical patients was similar to that in ILI-patients. Duration of infectiousness as measured by viral culture lasted approximately until illness days 4–6. Viral load did not seem to be influenced by antiviral therapy, age or vaccination status. Asymptomatic/subclinical infections occur infrequently, but may be associated with substantial amounts of viral shedding. Presymptomatic shedding may arise in one third of cases, and shedding characteristics appear to be independent of (seasonal or pandemic) (sub)type, age, antiviral therapy or vaccination; however the power to find moderate differences was limited.

21 February 2013 in Eurosurveillance
Verified
Journal Article
Open access
UBUdo Buchholz
Udo Buchholz
MMM A Müller
M A Müller
ANA Nitsche
A Nitsche
ASA Sanewski
A Sanewski
NWN Wevering
N Wevering
WHW Haas
W Haas
On 24 October 2012, a patient with acute respiratory distress syndrome of unknown origin and symptom onset on 5 October was transferred from Qatar to a specialist lung clinic in Germany. Late diagnosis on 20 November of an infection with the novel Coronavirus (NCoV) resulted in potential exposure of a considerable number of healthcare workers. Using a questionnaire we asked 123 identified contacts (120 hospital and three out-of-hospital contacts) about exposure to the patient. Eighty-five contacts provided blood for a serological test using a two-stage approach with an initial immunofluorescence assay as screening test, followed by recombinant immunofluorescence assays and a NCoV-specific serum neutralisation test. Of 123 identified contacts nine had performed aerosol-generating procedures within the third or fourth week of illness, using personal protective equipment rarely or never, and two of these developed acute respiratory illness. Serology was negative for all nine. Further 76 hospital contacts also tested negative, including two sera initially reactive in the screening test. The contact investigation ruled out transmission to contacts after illness day 20. Our two-stage approach for serological testing may be used as a template for similar situations.

12 January 2010 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
CWChris J Williams
Chris J Williams
BSBrunhilde Schweiger
Brunhilde Schweiger
GDGenia Diner
Genia Diner
FGFrank Gerlach
Frank Gerlach
FHFrank Haaman
Frank Haaman
UBUdo Buchholz
Udo Buchholz
Influenza immunisation for healthcare workers is encouraged to protect their often vulnerable patients but also due to a perceived higher risk for influenza. We aimed to compare the risk of influenza infection in healthcare workers in acute hospital care with that in non-healthcare workers over the same season.